Researchers use semaglutide as a tool compound to probe how chronic GLP-1R activation modulates appetite-related neuronal firing, neuroinflammation markers, and emerging neuroprotective research questions in Alzheimer's and Parkinson's model systems
GLP-1 receptor agonists can also be utilized to treat obesity, liver cirrhosis, cardiovascular disease, and other disorders
The underlying GLP-1 component shares Semaglutides established durability
GLP-1s can be expensive, but many insurance plans now cover them for patients who qualify
However, as the GLP-1 albumin fusion and unfused albumin have the same theoretical pI, and only small differences in pH-dependent net charge, this probably does not explain the discrepancy between their FcRn binding properties and cellular handling or plasma half-life
Please note that the cost of any IV treatments and IV supplies will be an extra charge